chrisvoncsefalvay/vaers-outcomes huggingface dataset:
dulled taste buds; dizziness; thirst; pain at injection site; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: ER8732) via an unspecified route of administration in the left arm on 24Mar2021 at 9:00 (at the age of 40-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. Patient was allergic to sulfa. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 14:00, the patient experienced dulled taste buds, dizziness, thirst, and pain at injection site. The patient did not receive any treatment for the events. The events didn't result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dulled taste buds, dizziness, thirst and pain at injection site was unknown at the time of reporting.   No follow-up attempts are needed. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: updated Relevant medical history verbatim to known_allergies sulfa. Vaccine Facility Information updated.
PATIENT RECEIVED PROQUAD ON 8/11/17 AND VARIVAX ON 4/2/15. THE PATIENT NOW HAS CHICKENPOX 9/7/17.
Raised blood sugar to over 350 the night of 12/29 body ache and chills
She immediately started having hot flashes after receiving vaccination, that have not resolved since time of patient reporting ADR on 1/14/21 (~12 days in duration). She also experienced a bad headache with blood vessel rupturing in her eyes.
pt devel fever of few hr then 3wk later inc fever 105.4 w/fine red dots everywhere lasted 24hr then 3-4 days later unable to walk on rt leg;went to ER;lymph nodes enlarged p/1wk;
20APR92 13-15 employees were given both TB skin test & 1st dose of Engerix-B; 27APR92 TB test read as sl pos; reporter indicated a poss interference by Engerix-B w/TB test;
patient received dose 1 of moderna covid vaccine at 9:32am; pt c/o redness/irritation around chest /neck area at  09:42;  50mg oral benadryl and 20mg oral pepcid administered;  10:23 redness almost resolved and itching almost completely resolved; patient sent home with instructions on reporting to ER if symptoms should worsen and instructions on premedications for next vaccine.  pt verbalized understanding of all instructions.
Swelling at site within 24 hours continued to increase over next 72 hours. Edema from left shoulder to mid forearm mostly lateral aspect + warm tender. No erythema.
Patient received 1 dose of Janssen COVID-19 vaccine on 3/17/2021 per Database, subsequently tested positive for COVID-19
This case was reported by a pharmacist via call center representative and described the occurrence of injection site erythema in a 76-year-old female patient who received SHINGRIX (batch number GZ29L, expiry date 23rd May 2021) for prophylaxis. On 15th January 2019, the patient received SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced injection site erythema and injection site pain. On an unknown date, the outcome of the injection site erythema and injection site pain were unknown. It was unknown if the reporter considered the injection site erythema and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The patient experienced redness and soreness at injection site after SHINGRIX vaccine. The reported batch number g729L was corrected to GZ29L as per sales data review.
20min after mmrv developped hives over body, 6ml given po of Diphenhydramine per MD, referred to Allergy/Immunology .
Patient reports after second vaccine had an episode of fever and illness that was expected. Then has had feeling new onset chronic shortness of breath that has not resolved.  Previously an athlete that has never had issues with chest pain or shortness of breath in the past.
This case was reported by a consumer via call center representative and described the occurrence of hemorrhage in a male patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced hemorrhage (serious criteria GSK medically significant). On an unknown date, the outcome of the hemorrhage was recovered/resolved. It was unknown if the reporter considered the hemorrhage to be related to SHINGRIX. Additional information received as follows: The case was reported by the patient's wife. The age at vaccination was not reported but it could be 55 or 56 years. The reporter said that the patient did not have any symptoms after the 1st dose, just noted that he bled more after the 2nd dose compared to the 1st dose of SHINGRIX. For tolerance to next dose, refer case US2018175501.
Child received varicella vaccine 11/08/2002.  Diagnosed with disease 04/04/2006.
w/in minutes was crying for greater than 1 hr; devel urticarial rash w/angioedema of ears by 1 hr;
Fever, rash pustules, pruritus. Prior VAERS form sent in was determined by a dermatologist to be infected dermatitis and not chicken pox.
After injection, I had normal mild pain at injection site for 2 days.  But rather than diminishing, pain and weakness in my shoulder and upper arm increased.  When it became hard to remove a T-shirt, I went to my doctor.  He recommended a course of ibuprofen which reduced pain somewhat.  Then physical therapy which I have just started. I CANNOT BE SURE THAT MY PAIN AND LIMITED MOTION IN MY LEFT ARM RESULTED FROM THE INJECTION.  I MAY HAVE UNKNOWINGLY INJURED IT IN SOME OTHER WAY.
pt recvd vax & exp arthralgia, paresthesia, numbness of fingers, shoulder & knee pain;
sore arm, fever, body aches, body chills, fatique, sleeplessness lasted 30 hours
the injection site was swollen the next day; i couldn't get hurt to touch the arm; right after the shot i had a tingling tongue for the whole day; This is a spontaneous report from a contactable consumer. The consumer (patient) reported that, A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: fc3184 and expiry date: not reported) via an unspecified route of administration on 02Sep2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medication were not reported. The patient stated that, right after the shot I had a tingling tongue for the whole day on 02sep2021 and the injection site was swollen the next day, I couldn't get hurt to touch the arm on 03sep2021. Outcome of the event right after the shot I had a tingling tongue for the whole day was recovered on an unspecified date 2021 and other events were unknown.  Follow-up attempts are completed. No further information is expected.
I had a boom, boom, boom that switching to a thumping noise.; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (I had a boom, boom, boom that switching to a thumping noise.) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017B21A and 025321A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced TINNITUS (I had a boom, boom, boom that switching to a thumping noise.). At the time of the report, TINNITUS (I had a boom, boom, boom that switching to a thumping noise.) outcome was unknown.            Concomitant product use was not provided by the reporter.  No treatment information was provided.
About 12 hours after vaccination the injection site was warm, itchy, red, and swollen and continued to increase in size over the next 24 hours. It went from about the size of a quarter to the size of a small orange. Between 24-48 hours after vaccination, the redness and swelling decreased but the site remained slightly pink in color and itchy. A week after injection the swelling is gone and the color is back to normal, however, slight itchiness remains.
PANIC ATTACK; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced panic attack. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of panic attack was not reported. This report was non-serious. This case, from the same reporter is linked to 20210410701.
Myalgia, Fever, Chills, pain at injection site Narrative:  Other Relevant History:
Information has been received from a medical assistant referring to an adolescent patient of unknown age and gender. Concurrent conditions, medical history and concomitant medications were not reported. On 23-SEP-2015, the patient was vaccinated with second dose of improperly stored VAQTA, lot # L018499; expiry: 25-FEB-2017 (dose, route and frequency unspecified). No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Continual headache.  Subsides briefly with Tylenol or Advil but reoccurs.
Swelling of arm, rash, and very hot in temperature.  Taking pain killer medication.
Lightheaded, tingling sensation over all of body.  Difficulty in swallowing prompting call of paramedics.  Vitals were taken and after 30 minutes was deemed okay to return home.  No hives.  Instructed to take Benadryl
Patient slowly developed rash on arm while waiting after receiving vaccine, we gave patient Benadryl and kept her for additional observation before she left with her husband at around 9:30am. We followed up with patient at 11:30am and she said the rash had not worsened and she felt fine, we advised patient to closely monitor rash and if symptoms worsened to seek medical attention immediately.
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Feb-2021 at 2:25 PM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 14-Feb-2021 at 2:25 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The age of patient was provided as 29.02.  Concomitant products were not provided.  On 09-Feb-2021, vaccines with batch number 031L20A were moved to the fridge. On 13-Jan-2021, 30 vials were moved to clinic. On the same day at 09 AM to 11 AM vials underwent temperature excursion with temperature 32 degrees Fahrenheit and at 02 PM vials underwent temperature excursion with 35 degrees Fahrenheit. The condition of vaccine prior to vaccination was not frozen. The vaccine beyond use date was reported as 10-Mar-2021.  It was reported that, the storage condition at the time of the excursion was cooler storage during high-pace COVID-19 vaccination clinic.  The vials were only punctured right before administration and all doses were drawn from the vial due to high-pace clinic.  Temperature recordings were taken using a Fisherbrand traceable temperature monitor at every hour.  The vial was not in a frozen state at the time of vaccine administration.  It was reported that, the patient was administered with vaccine that experienced more than 1 temperature excursion during 33 weeks on 2021. The health care professional explained that each time a vial was put into a cooler, there was a period of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34- or 35-degree Fahrenheit.  Treatment medications were not reported.   This case was linked to MOD-2022-566976 (Patient Link).
forced to take the flu shot every year and every year he got terribly sick; Initial information received on 18-Nov-2020 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via social media.  This case involves male patient of unknown age who every year got terribly sick (illness), after receiving INFLUENZA VACCINE.  The patient's past vaccinations included flu shot every year and every year got terribly sick.  Medical history, medical treatment(s), concomitant medication(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious sickness (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  No laboratory data reported.  It was not reported if the patient received a corrective treatment.  At the time of reports, the outcome was not reported for the event illness.  There will be no information on the batch number for this case.
Flu-like symptoms with aches and a headache for 2 days. The nurse said these side effects  could happen and were fairly common. Lasted for 2 days.
patient experienced fever (102), chills, nausea, splitting headache on next day.  2nd day, she developed a fever blister on lower lip.  she is now reporting as she is getting itchy spots on her legs
4:18 .5mg H1N1 in (L) deltoid given. 4:30 reported arm warm. Urticaria progressed over neck, back, chest & (R) arm. 4:35 50mg diphenhydramine given (R) arm IM BP 160/90; 4:50 BP 160/90 AP 84. 5:10 BP 160/90 AP 84. Given 2 tabs 25 mg diphenhydramine before bedtime if needed.
Developed pain in lower left leg that became so concerning that a doctor appointment was made. Visited doctor on  3/4/21 and doctor thought it might be a blood clot. Ultrasound ordered 3/10/2021, blood clot in left leg confirmed. Second ultrasound done on 3/12/2021 and blood clot was again re-confirmed
Six hours after vaccine, experienced chills, headache, body aches the first day into the next day and gone by end of 2nd day Ringing in my ears which I've never had before started about 10 days after receiving vaccine and I am still experiencing
2/15/2021 covered with unbelievable rash from my neck to my ankles!! Lasted for more than 12 days and was extremely itchy.
Pregnant client was inadvertently given a second flu vaccine one week after the first vaccine.  No adverse effects were reported by client.
persistent cough for weeks and was diagnosed with pneumonia complicated by GPC bacteremia with leukocytosis; persistent cough for weeks and was diagnosed with pneumonia complicated by GPC bacteremia with leukocytosis; Information has been received from a lawyer concerning a case in litigation and refers to a female patient of unknown age. No information regarding the pt's medical history, concurrent conditions and concomitant medications was reported. On or about 18-JUL-2017, the pt was inoculated with zoster vaccine live(ZOSTAVAX) injection (dose, route of administration, vaccination site, lot # and expiry date were not specified) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after receiving zoster vaccine live (ZOSTAVAX), the pt suffered a persistent cough for weeks and was diagnosed with pneumonia complicated by gram-positive (GPC) bacteremia with leukocytosis. As a direct and proximate result of the Company's defective zoster vaccine live (ZOSTAVAX) vaccine, the pt's symptoms have resulted in physical limitations not present prior to using the Company's product. The pt also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of the manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the pt sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the pt suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the pt has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was not recovered. The causality was related.   The events of pneumonia complicated by gram-positive (GPC) bacteremia with leukocytosis were considered to be disabling.  Upon internal review, the events of pneumonia complicated by gram-positive (GPC) bacteremia with leukocytosis were determined to be medically significant.
Woke up in the middle of the night with a fever and massive headache. Could not go back to sleep for hours. At times I was shaking. Headache and tiredness for the whole next day, could not work.
Extreme muscle fatigue/ failure to the point of not being able to walk without assistance.   Extreme mental and physical weakness.
Pt states he started feeling body aches/chills at 16:30 this date, recovered inoculation 08:00 hrs this date. Pt state he also had stomach cramps at same time. Pt doubled over in pain at 21:00 hrs this date 109/54 BP, P 88.
2nd Dose was Given 2 Weeks and 1 Day after the 1st; Initial Report Received on 10-Sep-2021  A registered nurse in the US reported that a 31 year-old female (race and ethnicity not provided) received a second dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization two weeks and 1 day after the first dose.   Relevant medical history was not reported.    Relevant concomitant medications were not reported.  On 23-Aug-2021, the patient received the first dose of HEPLISAV-B (Lot #, expiration date, NDC #, and serial number not reported).  On 07-Sep-2021, two weeks and 1 day after the first dose of HEPLISAV-B, the patient was given the second dose of HEPLISAV-B (Lot # 934975, expiration date 13-Aug-2022, NDC # 43528-003-05, and serial # 565252922606) in the left deltoid. No adverse reactions were reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
About 24 hours after the vaccines, the left upper arm became red, warm and tender to touch.  They applied ice to it but today it seems like a larger area of redness, so Mom would like him checked.  No fever or numbness or tingling of the left arm or fingers. Patient was seen 10/7/19 in clinic.
This is a spontaneous report from a contactable Physician and a consumer (Office staff). A female patient of an unspecified age and ethnicity received TRUMENBA first dose via an unspecified route of administration from an unspecified date at single dose for immunization. The patient's medical history and concomitant medications were not reported. The patient experienced swollen arm and chills on an unspecified date with outcome of unknown.
Pt stated she received the Prevnar shot on Friday, and had diarrhea on Monday morning.  Pt did not seek medical attention as symptoms resolved.
Patient fainted, shaking while sitting (had to monitor patient for 15 minutes post vaccine)
Pt was very nervous and worked up about getting "shots" and the thought of them "hurting". Pt was seated on exam table. HPV vaccine given in left deltoid. Pt started crying stating "the shot hurt really bad". Pt saw her arm had a spec of blood where the injection was given. She slumped over  and passed out. The CMA was able to safely lay on back on the exam table. Pt was out for a few seconds. Cool towel was placed to her head and she drank some apple juice. She perked up and Mom instructed to administer the menactra immunization. Pt received this injection in the right arm while lying down. She tolerated well and after 10 minutes was able to ambulate out of office without difficulty.
2/27/02-Patient received MMR, Comvax, varivax slight redness and swelling of arms noted, then resolved.  3/7/02-slight redness noted on left deltoid region then progressively worsened and tender to touch  3/8/02-Clinic appointment-diagnosis cellulitis left deltoid region (1 cm firm red tender) 3/11/02- Cellulitis-improving
Father stated pt received 2 shots in left arm on Monday AM approx 9:30 AM and stated by 3 PM he took bandaid and pt c/o hurting. No intervention with cool compress or Tylenol. States on 9/30/03 father noticed swollen from left shoulder to left elbow and hard and painful. Continued on continuing nights.
Pt recvd 2 doses of Engerix-B & 7AUG92 w/in 10-20 minutes of dose 2 had tingling rt arm, severe heart palpitations, SOB, confus, disorientation; seen by MD; hospitalized overnight; recvd DPH, Oxygen, Epi, Decadron;
Pt recv vax on 10/21/98; on 10/22/98 pt exp erythema & pitting edema on arm; pain at vax site; tx=ice, anti-inflammatory, elevate arm
I had Covid arm after the 2nd shot. I had a rash that was red and warm to the touch that extended down to my elbow. It was itchy and sore. I had a sore throat. It lasted for about 3 1/2 weeks. I contacted my doctor and he told me to take an antihistamine. The medicine helped it out a little, it didn't go away completely, and I have a knot where I received the shot.
Slight redness at injection site very small with slight elevation - "size of pimple"; experienced pressure in head, behind eyes below, and pressure in her ears; went home and experienced mild dizziness when laid down, arm now sore; today now sore at injection site, increase pressure in head and below eyes; no fever; today became dizzy and disoriented; balance and coordination issues.
-patient got flu & pneumo shots on Wed 9-9-09 at flu shot/vaccination clinic at Kroger Pharmacy #825 -2 days later (on 9-11-09), patient's wife noted redness & swelling around elbow on vaccination arm-patient came into pharmacy on Friday evening-elbow area was red, swollen, not warm to touch-sent to nurse practitioner next door-> -was diagnosed with cellulitis (may or may not related to vaccines) & given prescription folz pack -per patient's wife->almost all cleared up by Mon 9-14-09.
Pt had 2 cm area of red and swollen noted on the morning after the vaccine was given. Reported fever of 102 F the same AM. Was not documented in office.